Cyclin-dependent kinase 5 (Cdk5) is widely expressed although kinase activity has been described preferentially in neuronal systems. Cdk5 has an impact on actin polymerization during neuronal migration and neurite outgrowth and deregulation of the kinase has been implicated in the promotion of neurodegeneration. Recently it was shown that Cdk5 modulates dopamine signaling in neurons by regulating DARPP-32 function. In addition, Cdk5 phosphorylates munc-18 and synapsin I, two essential components of the exocytotic machinery. We have shown by reverse transcriptase-polymerase chain reaction, immunocytochemistry, and Western blotting that Cdk5 is present in the insulin-secreting pancreatic ␤-cell. Subcellular fractionation of isolated ␤-cells revealed a glucose-induced translocation of membrane-bound Cdk5 protein to lower density fractions. Inhibition of Cdk5 with roscovitine reduced insulin secretion with ϳ35% compared with control after glucose stimulation and with ϳ65% after depolarization with glucose and KCl. Capacitance measurements performed on single ␤-cells that expressed a dominantnegative Cdk5 mutant showed impaired exocytosis. The effect on exocytosis by Cdk5 appeared to be independent of changes in free cytoplasmic Ca 2؉ concentration. Taken together these results show that Cdk5 is present in ␤-cells and acts as a positive regulator of insulin exocytosis.
Cyclin-dependent kinase 5 (Cdk5) is widely expressed although kinase activity has been described preferentially in neuronal systems. Cdk5 has an impact on actin polymerization during neuronal migration and neurite outgrowth and deregulation of the kinase has been implicated in the promotion of neurodegeneration. Recently it was shown that Cdk5 modulates dopamine signaling in neurons by regulating DARPP-32 function. In addition, Cdk5 phosphorylates munc-18 and synapsin I, two essential components of the exocytotic machinery. We have shown by reverse transcriptase-polymerase chain reaction, immunocytochemistry, and Western blotting that Cdk5 is present in the insulin-secreting pancreatic ␤-cell. Subcellular fractionation of isolated ␤-cells revealed a glucose-induced translocation of membrane-bound Cdk5 protein to lower density fractions. Inhibition of Cdk5 with roscovitine reduced insulin secretion with ϳ35% compared with control after glucose stimulation and with ϳ65% after depolarization with glucose and KCl. Capacitance measurements performed on single ␤-cells that expressed a dominantnegative Cdk5 mutant showed impaired exocytosis. The effect on exocytosis by Cdk5 appeared to be independent of changes in free cytoplasmic Ca 2؉ concentration. Taken together these results show that Cdk5 is present in ␤-cells and acts as a positive regulator of insulin exocytosis.
Insulin is stored in secretory granules in pancreatic ␤-cells and upon stimulation with secretagogues insulin is released by exocytosis. Exocytosis has been suggested to be mediated by the same core fusion machinery that traverses intracellular membrane traffic in all cells (1) (2) (3) . It was reported that the membrane fusion event required the N-ethylmaleimide sensitive factor (NSF), 1 and soluble NSF Attachment Proteins, ␣-, ␤-, and ␥-SNAP (1, 2) . In addition to NSF and SNAPs, a 7 S core complex with SNAp receptors or "SNARE" proteins corresponding to the vesicle component synaptobrevin/vesicular-associated membrane protein, as well as the plasma membrane proteins SNAP-25 (synaptosomal-associated protein of 25 kDa) and syntaxin were necessary for neuronal exocytosis (3) . The SNARE hypothesis proposes that the SNARE proteins form trans-complexes between adjacent membranes, thereby forcing them to proximity. After association of ␣-SNAP, the ATPase NSF completes the reaction by disassembling the SNARE complex leading to membrane bilayer mixing (3) . More recently, trans-SNARE pairing and NSF activity has been suggested to act either prior to docking of vesicles or after membrane bilayer mixing (4 -9) . Initially the SNARE proteins were regarded as neuron-specific. However, syntaxin, SNAP-25, synaptobrevin/ vesicular-associated membrane protein, and other synaptic proteins regulating neuronal exocytosis have also been identified in pancreatic ␤-cells, suggesting that the mechanism for insulin secretion is similar to that of neurotransmitter release from synaptic vesicles in neurons (10 -13) . Regulated secretion of insulin from pancreatic ␤-cells has to be tightly controlled to ensure glucose homeostasis in the body. The capacity of the ␤-cell to respond to stimulation is determined by several different signaling pathways. One important feature of these pathways is the phosphorylation cascade of a wide range of cellular substrates. Many different kinases such as protein kinase C, cAMP-dependent protein kinase (protein kinase A), Ca 2ϩ /calmodulin-dependent kinase II, mitogen-activated protein kinases, and protein-tyrosine kinases are present in the islets (14) . From neuronal systems it is known that protein phosphorylation of synaptic proteins plays significant roles in modulating different steps during exocytosis and synaptic vesicle recycling (15) . Presumably, protein kinases are also important players in the managing of secretory granules in the pancreatic ␤-cell. However, data regarding the physiological relevance for a particular kinase in the regulation of insulin secretion is often contradictory (reviewed in Ref. 14) .
Cyclin-dependent kinases (Cdks) and their activator molecules (cyclins) are heterodimers known to be powerful regulators of cell division progression (16 -18) . Although Cdk5 is expressed in most mammalian tissues and interacts with the widespread D-type cyclins, this association apparently does not result in an active kinase (19, 20) . The recognition of Cdk5 activity in post-mitotic neurons in the central nervous system suggested functions unrelated to cell cycle control (reviewed in Ref. 21 ). Neuronal Cdk5 activation was found to be mediated by complex formation with proteins exhibiting only limited homology to classical cyclins (22) (23) (24) (25) . Cdk5 is a proline-directed ser-ine/threonine kinase and phosphorylates neurofilaments (26 -28) and the microtubule-associated protein Tau (22, 29) . It has been suggested that deregulation of Cdk5 results in hyperphosphorylation of Tau, a prominent trait found in post-mortem brains of patients with Alzheimer's disease (30) . Furthermore, it has been reported that Cdk5 promotes neurite extension of cultured cortical neurons and other mechanisms associated with actin polymerization (31) (32) (33) (34) . A targeted disruption of the gene for Cdk5 results in abnormal brain development and perinatal death (35) . Lately, both synapsin I and munc-18 have been reported to be substrates for Cdk5, suggesting that Cdk5 might be a regulator of neuronal exocytosis (36 -39) . Interestingly, it was also recently reported that Cdk5 modulates dopamine signaling by phosphorylating dopamine and adenosine 3Ј,5Ј-monophosphate-regulated phosphoprotein of 32 kDa (DARPP-32) (40, 41) . In the present study we report that Cdk5 is expressed outside the nervous system in the insulin-secreting pancreatic ␤-cell and that this kinase positively affects insulin exocytosis.
EXPERIMENTAL PROCEDURES
Materials and Chemicals-Expression constructs encoding wild-type (wt) and a dominant-negative (dn) form of Cdk5 were gifts of S. van den Heuvel (42) . In the dn Cdk5 mutant an Asp is changed to an Asn at amino acid 144. This amino acid substitution results in a catalytic inactive kinase (24, 31) . Antibodies used were a rabbit polyclonal antiCdk5 antibody, C8 (Santa Cruz Biotechnology), a mouse monoclonal anti-insulin antibody, HB125 (Biogenex), a mouse monoclonal antisyntaxin 1 antibody, HPC-1 (Sigma), and a mouse monoclonal anti-␣-tubulin antibody, DM 1A (Sigma). Secondary antibodies used for immunocytochemistry were Texas Red goat anti-mouse IgG (HϩL) conjugate purchased from Molecular Probes and fluorescein anti-rabbit IgG (HϩL) conjugate purchased from Vector Laboratories. The secondary antibodies used in Western blotting were horseradish peroxidaseconjugated anti-rabbit and anti-mouse immunoglobulins (Dako Corp.). Roscovitine was obtained from Calbiochem, diluted to a 10 mM stock in dimethyl sulfoxide (Me 2 SO), and used in a final concentration of 10 M. Fura-2/acetoxymetyl ester (Fura-2/AM) was obtained from Molecular Probes and used in a final concentration of 2 M.
Preparation of Islets and Single ␤-Cells-Mouse pancreatic ␤-cells were isolated from 10 -12-month-old non-inbred obese hyperglycemic mice (gene ob/ob) as described previously (43, 44) . Ob/ob islets are composed of more than 90% ␤-cells (44, 45) . The cells were seeded onto coverslips and cultured in RPMI 1640 culture medium containing 11 mM glucose supplemented with 10% (v/v) fetal calf serum, 100 IU/ml penicillin, 100 g/ml streptomycin, and 2 mM L-glutamine.
RT-PCR-Total RNA was isolated from mouse brain (C57BL6) and pancreatic islets (ob/ob) using the RNeasy Mini Kit according to the manufacturer's instructions (Qiagen). Reverse transcribed-polymerase chain reaction (RT-PCR) was performed using the SuperScript TM RT-PCR System (Life Technologies, Inc.). Cdk5-specific primers were designed and synthesized (GenSet) according to data base sequences (5Ј-ACTGTGTTCAAGGCTAAAAACC-3Јand 5Ј-CAATTTCAACTCCCCAT-TCC-3). The RT-PCR reactions were performed using 10 pmol of each primer and the following program: 30 min at 50°C and 2 min at 94°C, followed by 40 cycles of denaturing at 94°C for 1 min, annealing at 55°C for 1 min, and extension at 72°C for 1 min, ending with a final extension at 72°C for 7 min. The amplified PCR products were separated by electrophoresis on a 1.5% agarose gel and visualized by ethidium bromide staining. 1-Kilobase DNA ladder (Life Technologies, Inc.) was used as size marker.
Immunocytochemistry-Primary ␤-cells from ob/ob mice were cultured 2-3 days as described above. The cells were fixed, permeabilized, and stained as described previously (46) . The stainings were analyzed with a laser scanning confocal microscope (Leica TCS NT), equipped with a krypton/argon laser. The images were processed with Adobe Photoshop 5.0 software.
Tissue Homogenization and Western Blotting-Pancreatic islets isolated from ob/ob mice and brain tissue from C57BL6 were homogenized in buffer containing (in mM): 20 HEPES, 2 EDTA, 1 MgCl 2 , 1 phenylmethylsulfonyl fluoride and protease inhibitor mixture according to instructions from the manufacturer (Roche Molecular Diagnostics), pH 7.4. Postnuclear supernatants were ultracentrifuged at 100,000 ϫ g for 40 min to separate soluble and membrane fractions. Protein concentrations were determined using BCA protein assay reagent (Pierce) or Bio-Rad protein assay (Bio-Rad). Samples were separated on 10% polyacrylamide gels and transferred to polyvinylidene difluoride membranes (Amersham Pharmacia Biotech). Membranes were blocked in phosphate-buffered saline containing 3% blotto (Amersham Pharmacia Biotech) and 0.025% Tween 20 (Merck Eurolab) for 1 h and then probed with primary antibodies overnight at 4°C. After washing, membranes were incubated with horseradish peroxidase-conjugated immunoglobulins for 45 min at room temperature. Immunoreactive bands were detected by enhanced chemiluminescence (ECL plus, Amersham Pharmacia Biotech) after exposure to Hyperfilm (Amersham Pharmacia Biotech).
Subcellular Fractionation-Isolated islets from ob/ob mice were incubated for 1 h in RPMI 1640 culture medium containing 3 or 17 mM glucose and supplements as described above. The islets were washed three times in homogenization buffer containing (in mM): 20 HEPES, 1 MgCl 2 , 250 D-sucrose, 2 EDTA, 1 phenylmethylsulfonyl fluoride, 3 or 17 glucose as well as 5 g/ml each of antipain, aprotinin, leupeptin, and pepstatin, pH 7.4. Thereafter the islets were homogenized in 250 l of homogenization buffer and shortly centrifuged to pellet nuclei. The supernatant was collected and the pellet was subjected to another homogenization and centrifugation as described above. The two supernatants were pooled and loaded onto a 4.4-ml linear sucrose density gradient (prepared from 0.6 and 2 M sucrose stock solutions). The gradient was centrifuged at 35,000 rpm for 18 h in a Beckman L8 -55 ultracentrifuge in a SW50 rotor and 15-16 fractions (300 l each) were collected from the top of the gradient. The linearity of the gradients was examined by measuring the refractive index of each fraction. The fractions were frozen until analyzed by immunoblotting. Equal amounts of protein from each fraction were subjected to SDS-polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride membranes. Membranes were incubated with appropriate antibodies followed by ECL as described above. Chemiluminescence was detected by using a CCD camera (LAS 1000, Fuji Photo Film Co., Ltd.), that provides optimal linearity of signal intensity. The obtained signals were quantified using the Image Gauge 3.12 software (Fuji Photo Film Co., Ltd.).
Insulin Release from Roscovitine-treated Cells-␤-Cells isolated from ob/ob mice or lean mice were preincubated for 4 h in RPMI 1640 culture medium with additions as described above, and supplemented with 10 M roscovitine, a potent inhibitor of Cdk5 activity (47), or with an equal volume of Me 2 SO as control. Insulin release was studied in perifused ␤-cell aggregates mixed with Bio-Gel P-4 polyacrylamide beads (BioRad), in a 0.5-ml column at 37°C. The cells were perifused with 3 mM glucose for 20 min, followed by a 20-min exposure to 11 mM glucose, returned back to 3 mM glucose for 20 min, and finally co-stimulated with 11 mM glucose and 25 mM KCl for 20 min. Roscovitine and/or Me 2 SO were included in all solutions during the experiment. The flow rate was 0.2 ml/min and 2-min fractions were collected. Insulin release was assayed by solid phase radioimmunoassay (RIA), using rat insulin as standard (Novo Nordisk). The basal level of insulin secretion was determined as the mean value from 10 data points of the first 20 min in 3 mM glucose. The area under the curve was examined by cutting out the curves, using the mean values, and weighing the obtained pieces on an analysis scale.
Capacitance Measurements on Transfected Cells-Single mouse pancreatic ␤-cells from adult ob/ob mice were transfected with either wild-type (wt) pCMV-Cdk5 or dominant-negative (dn) pCMV-Cdk5 in combination with pIRES2-EGFP (CLONTECH), using the LipofectAMINE 2000 technique (Life Technologies, Inc.). For mock transfection, only pIRES2-EGFP was transfected. The transfected cells were cultured for 2-4 days on coverslips. The cells expressing enhanced green fluorescent protein (EGFP) were selected for whole cell patch clamp capacitance measurements. Electrodes were made from borosilicate glass capillaries, fire-polished, and coated with Sylgard close to the tips. The electrode resistance ranged between 2 and 4 M⍀ when the pipettes were filled with the intracellular solutions. The electrode offset potential was corrected in the bath prior to gigaseal formation. Conventional whole cell recordings were performed with an EPC-9 patch clamp amplifier together with LockIn extension of PULSE software (HEKA Elektronik). A sinewave stimulus (500 Hz, 20 mV peak to peak) was superimposed onto a DC holding potential of Ϫ70 mV. The resulting currents were filtered at 2 kHz and sampled at 10 kHz. The capacitance traces were imported to IGOR Pro (WaveMetrics, Inc.). The data were analyzed with a PC using IGOR Pro. The standard extracellular solution consisted of (in mM): 138 NaCl, 5. 35M) . The stage of the microscope was thermostatically controlled to maintain a mean temperature of 37 Ϯ 1°C in the chamber. The microscope was connected to a SPEX fluorolog-2 CM1T11I system for dual wavelength excitation fluorimetry. Various treatments during recordings were done using a perifusion system attached to the chamber (see below for the different treatments). The excitation wavelengths generated by two monochromators were directed to the cells by a dichroic mirror. The emitted light, selected by a 500 -530-nm band pass filter, was directed to a CCD imaging system. The emissions at the two excitation wavelengths of 340 nm (F 340 ) and 380 nm (F 380 ) were used to calculate the fluorescence ratio (F 340 /F 380 ), yielding relative changes in cytoplasmic free Ca 2ϩ concentration, [Ca 2ϩ ] i . Cells were pretreated with 10 M roscovitine or Me 2 SO for 3.5-5 h, loaded with fura-2/AM for 45 min, and stimulated with 25 mM KCl for 2 min. Following these experiments, the cells were stimulated with glucose to verify that the recorded cells were glucose responsive ␤-cells. Cells from each group were averaged for each time point and a composite recording was plotted. Rate of initial response, peak delta ratio, and area under curve were analyzed.
RESULTS

Cdk5
Is Expressed in Pancreatic ␤-Cells-To examine if transcription of Cdk5 mRNA occurred in pancreatic islets we performed RT-PCR using Cdk5-specific primers. RNA isolated from brain served as a positive control. A fragment of identical size was amplified from islet and brain RNA. The length of the fragment was consistent with the expected length of about 380 base pairs, estimated from the nucleotide sequence (Fig. 1A) . To investigate if the Cdk5 protein was expressed in pancreatic ␤-cells, ␤-cells and brain tissue were homogenized and ultracentrifuged to receive a soluble and a membrane fraction. Cdk5 immunoreactivity was detected in ␤-cell homogenate, both in soluble and membrane fractions. However, Cdk5 was enriched in the soluble fraction. The distribution of membrane-bound and soluble Cdk5 protein in ␤-cells was similar to the distribution of Cdk5 protein in brain homogenate (Fig. 1B) . To further confirm the presence and subcellular localization of Cdk5 protein in single ␤-cells we performed immunocytochemistry. Cdk5 exhibited a granular staining pattern, homogeneously spread in the cytoplasm. Double staining with insulin proved that Cdk5 was expressed in the ␤-cells and partially co-distributed with this hormone (Fig. 1C) . These results clearly show that Cdk5 mRNA and protein are expressed in insulin-secreting pancreatic ␤-cells.
Glucose Stimulation Changes the Subcellular Distribution of Cdk5-A specialized feature of pancreatic ␤-cells is their responsiveness to glucose. To analyze if glucose stimulation of pancreatic ␤-cells changes the subcellular distribution of Cdk5 we performed sucrose density gradients on unstimulated and glucose-stimulated ␤-cells. The fractions were analyzed by Western blotting. In unstimulated ␤-cells Cdk5 immunoreactivity was mainly detected in low density fractions (fraction 2-5) corresponding to cytosolic fractions, but also in middle density fractions (fraction 6 -10), resembling membrane-bound proteins ( Fig. 2A, top, and C) . The soluble protein ␣-tubulin served as a marker for cytosol ( Fig. 2A, middle) and syntaxin 1 was used as a plasma membrane marker (Fig. 2A, bottom) . In glucose-stimulated ␤-cells, Cdk5 immunoreactivity was still mainly detected in fractions 2-5, corresponding to the cytosol, but Cdk5 immunoreactivity in the plasma membrane fractions was notably diminished (Fig. 2, B, top, and C) . The distribution of ␣-tubulin and syntaxin 1 immunoreactivity were approximately the same in glucose-stimulated ␤-cells (Fig. 2B , middle and bottom) and unstimulated ␤-cells (Fig. 2A, middle and  bottom) . 
Roscovitine Inhibits Insulin Secretion-To investigate if
Cdk5 was involved in the regulation of insulin secretion, ␤-cells were pretreated with roscovitine for 4 h, a potent inhibitor of Cdk5 activity, or incubated with Me 2 SO as control. Insulin release was measured after perifusing the cells with 3 mM glucose, 11 mM glucose, and 11 mM glucose in combination with 25 mM KCl. The experiments were performed on cells isolated from ob/ob mice (Fig. 3A) and lean mice (Fig. 3B) . Treatment with roscovitine decreased glucose-induced insulin secretion, both in cells from ob/ob and from lean mice compared with controls. After depolarization with KCl the reduction in insulin secretion was more pronounced. Roscovitine treatment of ob/ob cells reduced glucose-induced insulin release by ϳ35% and insulin secretion induced by co-stimulation with glucose and KCl by ϳ65% (Fig. 3A) . In cells isolated from lean mice the corresponding numbers were ϳ50% (glucose) and ϳ65% (glucose ϩ KCl) (Fig. 3B) . The numbers were obtained by measuring the area under the curve for insulin secretion in control and roscovitine-treated cells. These data showed that roscovitine treatment prominently impaired insulin secretion from primary ␤-cell.
Cdk5 Is a Positive Regulator of Insulin Secretion-To confirm that the observed decrease in insulin secretion caused by roscovitine was specifically achieved by inhibition of Cdk5 activity, we performed transient transfection studies. Exocytosis from cells transfected with wt or dn expression constructs of Cdk5 were evaluated by whole cell patch clamp capacitance measurements. This technique is characterized by high time resolution and thus detects the dynamic changes in cell surface area reflecting exocytosis. As shown in 
FIG. 3. Effects of roscovitine treatment on insulin secretion.
␤-Cell aggregates were preincubated with 10 M roscovitine dissolved in Me 2 SO or Me 2 SO alone for 4 h and insulin release was studied by perifusing cells at 37°C with 3 mM glucose, 11 mM glucose, 3 mM glucose, and 11 mM glucose in combination with 25 mM KCl. Each treatment was 20 min. The insulin released after perifusion with 3 mM is designed as basal level. A, ␤-cells isolated from ob/ob mice, n ϭ 4 (B) and from lean mice, n ϭ 3. One asterisk (*) indicates significant difference (p Ͻ 0.05) from control, whereas § indicates a significant difference (p Ͻ 0.01).
Cdk5 (n ϭ 14) was significantly lower (p Ͻ 0.05) than that in wt Cdk5-transfected (n ϭ 14) or mock-transfected cells (n ϭ 14) (Fig. 4B) . These results confirmed that the decrease of insulin secretion observed during roscovitine treatment operated through selective inhibition of Cdk5.
Cdk5 indicator fura-2/AM to measure changes in [Ca 2ϩ ] i after KCl stimulation in roscovitine-treated and control cells. First, to examine a possible acute effect of roscovitine, ␤-cells were incubated with the inhibitor for 15 and 30 min. Both short-time incubations failed to cause any significant differences in [Ca 2ϩ ] i evoked by KCl (data not shown). In accordance with these results, compiled data obtained from cells treated with roscovitine for 4 h, n ϭ 67 cells (Fig. 5A) and Me 2 SO control group, n ϭ 53 cells (Fig. 5B) , did not reveal any significant alteration in [Ca 2ϩ ] i increases evoked by 2 min treatment with 25 mM KCl. Thus, we conclude that Cdk5 does not inhibit insulin secretion by means that notably influences the level of [Ca 2ϩ ] i .
DISCUSSION
In the present study we have demonstrated that both Cdk5 mRNA and protein are expressed in the pancreatic ␤-cell. Although Cdk5 is expressed in most mammalian tissues, this is the first report showing the presence of Cdk5 in primary ␤-cells. The main physiological stimulus for triggering release of insulin from pancreatic ␤-cells is glucose. The entry of glucose into the ␤-cell starts a cascade of intracellular events leading to membrane depolarization and Ca 2ϩ influx followed by transport, docking, priming, and subsequent fusion of secretory granules with the plasma membrane (49 -51) . Interestingly, in response to glucose stimulation Cdk5 exhibited a redistribution in the ␤-cell as revealed by subcellular fractionation. The majority of Cdk5 protein was found in lower density fractions both in unstimulated and glucose-stimulated ␤-cells.
However, a population of Cdk5 co-localized with the plasma membrane marker syntaxin 1 in unstimulated cells and translocated to the soluble pool present in lower density fractions after glucose stimulation. This observation showed that the redistribution of Cdk5 was a response to extracellular glucose stimulation.
In perifusion experiments insulin secretion was impaired by roscovitine, both after glucose stimulation and after stimulation by glucose in combination with a depolarizing concentration of KCl. The impairment of insulin secretion, as a response to inhibition of Cdk5 activity, was independent of changes in [Ca 2ϩ ] i . We could not detect any changes on KCl-evoked Ca 2ϩ influx either with acute or 4 h of treatment of isolated ␤-cells with roscovitine as compared with control cells. Although, no significant differences were observed on [Ca 2ϩ ] i , our data cannot completely exclude that there are minor fluctuations not detected with the fura-2 technique. Roscovitine is a potent inhibitor of Cdk5 and binds to the ATP-binding site in the kinase (47) . The concentration of roscovitine that was used in our experiments inhibits Cdk5 but could also affect Cdc2/cylin B, Cdk2/cyclin A, and Cdk2/cyclin E (47). However, by using terminally differentiated primary ␤-cells the inhibitory effect of roscovitine has on Cdk regulated cell cycle progression could presumably be neglected. To establish that the observed effect on insulin secretion was specifically, albeit maybe not exclusively, through the action of Cdk5 we performed transient transfections with wt and dn Cdk5 expression constructs in primary ␤-cells. Single ␤-cells expressing the exogenous proteins were analyzed by whole cell capacitance measurements. Cells that expressed the dn Cdk5 mutant displayed a smaller Ca 2ϩ -induced increase in membrane capacitance than cells transfected with wt Cdk5 or mock-transfected cells. This confirmed that the results obtained with roscovitine were due to specific effects of Cdk5. Although it is difficult to compare two different techniques such as capacitance measurements and radioimmunoassay, the capacitance measurements at the single cell level showed an approximate 20 -25% reduction of exocytosis from cells expressing dn Cdk5 compared with a reduction of as much as 65% of insulin secretion from roscovitine-treated cells. This difference in inhibition is most likely due to the fact that primary ␤-cells poorly express transfected DNA and hence a fraction of enzymatic active endogenous Cdk5 may still be present in the dn Cdk5 expressing cells. Transfection with wt Cdk5 did not significantly add to the Ca 2ϩ -induced increase of membrane capacitance. The most likely explanation to this result is that endogenous Cdk5 is present in large amounts compared with the less abundant regulatory subunits binding to and activating Cdk5.
Cdk5 is expressed in most mammalian tissues, but constitutive catalytic activity has only been found in neuronal systems (52) (53) (54) . In neurons Cdk5 has been shown to phosphorylate numerous substrates and thereby modulating several different intracellular signaling cascades that may directly or indirectly influence secretion. For example, both in neurons and in ␤-cells the cytoskeleton is pivotal for membrane vesicle transport (50, 55, 56) . Cdk5 is regarded as a neuron-specific Rac regulator causing hyperphosphorylation of the small GTPase Pak 1, and thereby modulating actin cytoskeleton dynamics (32) . Moreover, Cdk5 phosphorylates synapsin I (36), a phosphoprotein that cross-links synaptic vesicles to the cytoskeleton and facilitates mobilization and tethering of vesicles to the readily releasable pool. Synapsin I is a marker for small synaptic vesicles and even if synapsin I is present in pancreatic ␤-cells, no or very limited co-localization with insulin-containing secretory granules has been observed (57, 58) . Furthermore, Cdk5 phosphorylates neurofilaments (26 -28) and the microtubule-associated Tau protein (22, 29) . Recently Cdk5 was also shown to regulate axonal retograde transport, by utilizing NUDEL as substrate and thereby affecting the distribution of cytoplasmic dynein heavy chain along microtubules (59, 60) .
Interestingly, Cdk5 may also directly affect secretion by interactions with the exocytotic machinery. It has been found that Cdk5 interacts with munc-18 in vivo and in vitro and phosphorylates munc-18 in vitro (37, 38, 61) . Munc-18 is also present in ␤-cells where it is thought to operate as a negative regulator of exocytosis (62) . Conversely, it has been shown that targeted mutation of the munc-18 gene in mice results in a completely paralyzed organism and homozygous mutants die at birth (63) . The munc-18 null mutants exhibit a normal brain assembly but a complete lack of neurotransmitter release (63) . Munc-18 is thought to effect the exocytotic machinery via an interaction with syntaxin 1A, a core component in the exocytotic machinery, and perhaps munc-18 functions as a chaperone for syntaxin recycling. Syntaxin undergoes a dramatic conformational change during membrane fusion and possibly Cdk5 is instrumental in enabling syntaxin to dissociate from munc-18, allowing syntaxin to interact with SNAP-25 and thus promote secretion (64). However, the major kinase shown to phosphorylate munc-18 is protein kinase C (39). Another possibility is that Cdk5 operates even closer to the membrane fusion event. Recently, Mayer and co-workers (65) showed that protein phosphatase 1 (PP1) is essential for membrane bilayer mixing in yeast vacuolar fusion. In neostriatal neurons, the activity of PP1 is regulated by the phosphorylation status of DARPP-32. Protein kinase A phosphorylation of residue Thr-34 converts DARPP-32 into a potent inhibitor of PP1, whereas phosphorylation by Cdk5 of residue Thr-75 inhibits protein kinase A activity, resulting in activation of PP1 (40, 41) . Active protein phosphatase 1 has been shown to be required for glucose-stimulated insulin secretion (66) . Another substrate for Cdk5 is inhibitor 1 (I-1) , an inhibitor of PP1 (67) . In neurons, Cdk5 has been reported to phosphorylate amphiphysin 1 (68), a phosphoprotein that functions in synaptic vesicle endocytosis. So far it is unknown if amphiphysin 1 is present in pancreatic ␤-cells.
Most of the knowledge we have about the underlying mechanisms responsible for achieving regulated secretion is derived from studies of synaptic vesicles in neuronal systems. Since many neuronal exocytotic proteins are present in the pancreatic ␤-cell, insulin release has been suggested to be regulated in a similar way to neurotransmission from small synaptic vesicles. However, noteworthy is that there are proteins such as calcium-dependent activator proteins for secretion, that are specifically involved in the regulation of exocytosis via the dense-core and secretory vesicle pathways (69) . Importantly, the pancreatic ␤-cell also appears to express a selected repertoire of the SNARE protein variants that has been identified in neurons (10, 12, 70 -73) . Therefore, the substrates that Cdk5 activates in pancreatic ␤-cells and that are important for insulin exocytosis remain to be elucidated.
